According to Recursion Pharmaceuticals's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 43.8763. At the end of 2023 the company had a P/S ratio of 48.5.
Year | P/S ratio | Change |
---|---|---|
2023 | 48.5 | 31.72% |
2022 | 36.8 | -87.28% |
2021 | 289 |